UNSPSC 85266300: Diagnoses of amyloidosis

This classification denotes the group of activities that yields a diagnosis of Amyloidosis.

Amyloidosis is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems or Icd-10 as a Three Digit Category under code A00 Icd-10 Also Has The Following Amyloidosis Children in its Four-Character Category: E850 or Non-Neuropathic Heredofamilial Amyloidosis; E851 or Neuropathic Heredofamilial Amyloidosis; E852 or Heredofamilial Amyloidosis, Unspecified; E853 or Secondary Systemic Amyloidosis; E854 or Organ-Limited Amyloidosis; E858 or Other Amyloidosis; E859 or Amyloidosis, Unspecified AMYLOIDOSIS is listed in the Centers For Medicare & Medicaid Services International Classification Of Diseases Clinical Modification (Tenth Revision) (Icd-10-CM) as a Three Digit Category under code E85.

UNSPSC 85266300 Diagnoses of amyloidosis is a Class code that in recent state and local practice encompasses diagnostic imaging systems, ultrasound equipment, and laboratory specimen collection services supporting health system operations rather than amyloidosis-specific testing. State and local health systems, county medical centers, and law enforcement agencies are the primary buyers. San Mateo Medical Center's RFP for a diagnostic imaging PACS system (posted July 9, 2026, due August 7, 2026) solicits enterprise-grade picture archiving and communication infrastructure supporting radiology, cardiology, and dental imaging with EPIC integration—representing the largest and most complex recent opportunity under this code. Collier County, Florida's notice of intent to single source EchoNous ultrasound equipment and related services (posted April 1, 2026) and the Albuquerque Police Department's RFB for on-call phlebotomy technician services (posted January 26, 2026, due February 25, 2026) illustrate the breadth of diagnostic and specimen-collection work tagged to this code in practice. The code's nominal scope and the actual work being solicited show significant mismatch—recent opportunities focus on imaging systems infrastructure and specimen collection rather than amyloidosis diagnosis.

Geographic activity is concentrated in California, Florida, and New Mexico based on the most recent solicitations. San Mateo County's PACS implementation represents the largest procurement signal, with 9–12 month implementation timelines, 99.9% uptime requirements, and comprehensive HIPAA compliance mandates. The code shows limited recent activity overall; no standout repeat buyers emerge from the three opportunities identified. Issuers include county hospital systems (San Mateo), county procurement divisions (Collier), and municipal police departments (Albuquerque), suggesting that amyloidosis-code tagging may reflect administrative classification misalignment rather than targeted procurement strategy.